Guobang Pharma Ltd. (SHA:605507)
China · Delayed Price · Currency is CNY 23.86
-0.11 (-0.46%)
Apr 28, 2026, 3:00 PM CST
Guobang Pharma Market Cap
Guobang Pharma has a market cap or net worth of 13.33 billion as of April 28, 2026. Its market cap has increased by 17.00% in one year.
Market Cap
13.33B
Enterprise Value
11.56B
Revenue
6.09B
Ranking
n/a
PE Ratio
17.17
Stock Price
23.86
Market Cap Chart
Since August 2, 2021, Guobang Pharma's market cap has decreased from 26.21B to 13.33B, a decrease of -49.13%. That is a compound annual growth rate of -13.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 13.33B | -2.78% |
| Dec 31, 2025 | 13.71B | 19.12% |
| Dec 31, 2024 | 11.51B | 17.32% |
| Dec 29, 2023 | 9.81B | -33.66% |
| Dec 30, 2022 | 14.79B | -8.19% |
| Dec 31, 2021 | 16.11B | -38.53% |
| Aug 2, 2021 | 26.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Hepalink Pharmaceutical Group | 14.47B |
| Beijing Aosaikang Pharmaceutical | 14.13B |
| Zhejiang Medicine | 13.80B |
| Zhejiang Hisun Pharmaceutical | 13.53B |
| Shenzhen Chipscreen Biosciences | 13.25B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 13.02B |
| Shanghai Shyndec Pharmaceutical | 12.86B |
| Ningbo Menovo Pharmaceutical | 12.44B |